Peter Lipp Selected Research

Peter Lipp Research Topics

Disease

5	Cardiac Arrhythmias (Arrythmia) 12/2017 - 03/2012
4	Fibrosis (Cirrhosis) 12/2021 - 06/2012
3	Inflammation (Inflammations) 12/2021 - 01/2021
3	Heart Diseases (Heart Disease) 01/2020 - 07/2013
3	Hypertrophy 09/2015 - 08/2012
2	Cardiomegaly (Heart Hypertrophy) 01/2021 - 09/2015
2	Polymorphic catecholergic ventricular tachycardia 12/2017 - 03/2012
2	Atrial Fibrillation 08/2012 - 08/2010
1	Fatty Liver 01/2023
1	Vascular System Injuries 12/2021
1	Atherosclerosis 01/2021
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021
1	Ventricular Tachycardia 12/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2017
1	Thromboembolism 10/2016
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 07/2013
1	Sickle Cell Anemia (Hemoglobin S Disease) 05/2013
1	Thalassemia 05/2013
1	Insulinoma 08/2012
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 06/2012
1	Malignant Hyperthermia 03/2012
1	Alzheimer Disease (Alzheimer's Disease) 01/2012
1	Amyloid Plaque 01/2012
1	Drug-Related Side Effects and Adverse Reactions 01/2012
1	Neoplasms (Cancer) 10/2008
1	Melanoma (Melanoma, Malignant) 10/2008
1	Testicular Neoplasms (Testicular Cancer) 10/2008
1	Infections 07/2007
1	Heart Failure 09/2006
1	Vascular Remodeling 09/2006
1	Thrombosis (Thrombus) 12/2004

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2006
2	InflammasomesIBA 12/2021 - 01/2021
2	NLR ProteinsIBA 12/2021 - 01/2021
2	CationsIBA 01/2020 - 09/2015
2	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 12/2017 - 03/2012
2	AldosteroneIBA 10/2016 - 08/2012
2	Glucose (Dextrose)FDA LinkGeneric 01/2015 - 08/2012
2	CalciumIBA 06/2012 - 12/2004
1	SteroidsIBA 01/2023
1	Triglycerides (Triacylglycerol)IBA 12/2021
1	ApolipoproteinsIBA 12/2021
1	Lipoproteins (Lipoprotein)IBA 12/2021
1	AlarminsIBA 01/2021
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 01/2021
1	kaempferolIBA 12/2017
1	Anti-Arrhythmia AgentsIBA 12/2017
1	Hormones (Hormone)IBA 01/2016
1	ReninIBA 09/2015
1	Atrial Natriuretic Factor (ANF)IBA 09/2015
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2015
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2015
1	LipidsIBA 01/2015
1	Protein Isoforms (Isoforms)IBA 07/2013
1	NADPH Oxidases (NAD(P)H oxidase)IBA 07/2013
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2013
1	PhosphofructokinasesIBA 05/2013
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 08/2012
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 08/2012
1	Protein Kinases (Protein Kinase)IBA 08/2012
1	Transcription Factors (Transcription Factor)IBA 08/2012
1	GTP Phosphohydrolases (GTPases)IBA 08/2012
1	Tamoxifen FDA LinkGeneric 06/2012
1	Calmodulin (Calcium-Dependent Activator Protein)IBA 06/2012
1	Dantrolene (Dantrium)FDA LinkGeneric 03/2012
1	CalsequestrinIBA 03/2012
1	Cardiovascular AgentsIBA 01/2012
1	Amyloid (Amyloid Fibrils)IBA 01/2012
1	GangliosidesIBA 01/2012
1	Amyloid beta-PeptidesIBA 01/2012
1	Monomeric GTP-Binding ProteinsIBA 08/2010
1	HLA-A*02:01 antigenIBA 10/2008
1	AntigensIBA 10/2008
1	Neoplasm Antigens (Tumor Antigens)IBA 10/2008
1	EpitopesIBA 10/2008
1	Protein Kinase CIBA 07/2007
1	Prostaglandins EIBA 12/2004
1	Dinoprostone (PGE2)FDA Link 12/2004

Therapy/Procedure

2	Therapeutics 03/2012 - 01/2012
1	Ligation 12/2021